search
Back to results

How Different Sedatives Affect Hip Fracture Patient's Postoperative Delirium

Primary Purpose

Delirium in Old Age

Status
Unknown status
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Dexmedetomidine Hydrochloride
Propofol
Sponsored by
Shanghai Zhongshan Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Delirium in Old Age focused on measuring Delirium Dexmedetomidine elderly

Eligibility Criteria

65 Years - 90 Years (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Acquisition of informed consent,
  2. Patients with hip fracture surgery under lumbar anesthesia,
  3. Grade II to III based on American Society of Anesthesiologists ASA classification,
  4. Age ≥65 and ≤90 years old.

Exclusion Criteria:

  1. History of psychiatric disease or a disease needing long-term exposure to psychotropic drugs (dementia, schizophrenia), or history of alcoholic abuse.
  2. More than 8 errors in preoperative Simplified Psychology and Mental Status Questionnaire (SPMSQ) , and diagnosed as severe cognitive impairment.
  3. CAM positive diagnosed preoperatively.
  4. Any cerebrovascular accident occurring within 3 months, such as cerebral stroke or transient ischemic attack (TIA).
  5. Systolic pressure < 90mmHg and diastolic pressure < 60mm Hg at the preoperative follow up or HR< 50/minute.
  6. History of heat failure or EF<30% as shown by ultrasound cardiogram; degree 2 type 2 and degree 3 atrioventricular block. History of active heart disease (such as acute cardiac infarction, unstable angina pectoris)
  7. Severe abnormality in hepatic or renal function (severe abnormality in liver function: more than 2-times increase than upper normal limit in any one of the markers including ALT,, conjugated bilirubin, AST, ALP, total bilirubin; severe abnormality in renal function; Cr clearance<30ml/min), Scr>443μmol/L.
  8. Diabetes patients with severe complications of diabetes (Diabetic ketoacidosis, hyperosmolar coma, various infections, macrovascular diseases, and diabetic nephropathy)
  9. Patients with severe infection.
  10. Postoperative PaO2<60mmHg or SpO2<92%.
  11. Participation in clinical trials of other drugs within past 30 days.
  12. Disturbed verbal communication, and unable to accomplish the test on cognition.
  13. Patients with prosthesis fracture or restoration; hip fracture but complicated with severe trauma in other sites.
  14. Being allergic to investigational drug or having contradiction of lumbar anesthesia.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Dexmedetomidine Hydrochloride

    Propofol

    Arm Description

    Dex Group: 0.5 μg/kg of Dex is given 10 minutes before operation through injection pump during 15 minutes. After the operation starts, the initial pumping ratio of Dex is 0.5ug/kg/h and adjusted under BIS surveillance to keep BIS between 70-80 until 30 minutes before the end of surgery. Meanwhile, OAA/S grade is evaluated every 15 minutes to maintain OAA/S at grade 4. If discrepancy occurs, OAA/S prevails.

    Prop Group: Propofol is given with an initial ratio of 2-10mg/kg/h, when the operation starts. Under BIS surveillance, dripping rate is adjusted to keep BIS between 70-80 until 5 minutes before the end of surgery. Meanwhile, OAA/S grade is evaluated every 15 minutes to maintain OAA/S at grade 4. If discrepancy occurs, OAA/S prevails.

    Outcomes

    Primary Outcome Measures

    occurrence of postoperative delirium in postoperative 72 hours
    Evaluation of delirium is performed by trained investigational assistant who does not know the randomization of patients. Follow up is carried out before operation and at 9Am and 3Pm during post-operative day 1-3 (POD1-3). During follow up, RASS (Richmond Agitation-Sedation Scale, RASS) is used firstly to evaluate sedation of the patients, and for those with ARSS >-4 (-3~+4), the Confusion Assessment Method (CAM) is adopted for evaluation. A case consistent with delirium standard at any time point during follow up is determined to be delirium positive. Diagnosis should be confirmed for a CAM-positive patient by a psychological expert based on DSM-V standard

    Secondary Outcome Measures

    Consumption of analgesic
    the patients will receive patient-controlled intravenous analgesia,record the consumption of intravenous analgesia in the 48 postoperative hours
    Times of intra-operative occurrence of hypotension, bradycardia, hypertension and tachycardia that need treatment.
    assess the adverse effect of anaesthetic
    Score of quality of post-operative sleeping
    Score of sleeping quality is evaluated based on the some questions during follow up
    Hospital stay
    the duration from the day of operation to the date meeting discharge criteria as determined by doctor in charge
    Post-operative complications besides delirium
    complications besides delirium ,such as vomiting,nausea,hypotention,hypertention,bradycardia
    Mortality up to day 30 post to operation
    Data for 30-day survival is collected through telephone follow up by the assistant.
    pain score
    describe severity of the pain the patient feel using Numerical Rating Scale (NRS)

    Full Information

    First Posted
    September 14, 2017
    Last Updated
    December 11, 2017
    Sponsor
    Shanghai Zhongshan Hospital
    Collaborators
    First Affiliated Hospital of Guangxi Medical University, The Second Affiliated Hospital of Harbin Medical University, The First Affiliated Hospital of Nanchang University, Qianfoshan Hospital, Shanghai 6th People's Hospital, Tang-Du Hospital, Second Hospital of Shanxi Medical University, The First Affiliated Hospital of Soochow University, Shanghai Changzheng Hospital, The Fuzhou No 2 Hospital, Foshan Hospital of Traditional Chinese Medicine, Beijing Jishuitan Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03346226
    Brief Title
    How Different Sedatives Affect Hip Fracture Patient's Postoperative Delirium
    Official Title
    Influence on Incidence of Postoperative Delirium by Various Sedatives in Elderly Patients With Hip Fracture Under Lumbar Anesthesia: A Randomized, Control and Multi-center Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2017
    Overall Recruitment Status
    Unknown status
    Study Start Date
    January 1, 2018 (Anticipated)
    Primary Completion Date
    December 30, 2018 (Anticipated)
    Study Completion Date
    June 30, 2019 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Shanghai Zhongshan Hospital
    Collaborators
    First Affiliated Hospital of Guangxi Medical University, The Second Affiliated Hospital of Harbin Medical University, The First Affiliated Hospital of Nanchang University, Qianfoshan Hospital, Shanghai 6th People's Hospital, Tang-Du Hospital, Second Hospital of Shanxi Medical University, The First Affiliated Hospital of Soochow University, Shanghai Changzheng Hospital, The Fuzhou No 2 Hospital, Foshan Hospital of Traditional Chinese Medicine, Beijing Jishuitan Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    the hypothesis is that Dexmedetomidine seems to decrease incidence of post-operative delirium . one possible mechanism is that Dex have a minor influence on cognition, since it has no effect on GABA receptor,another is that Dex could induce a sleep similar to natural sleep, thereby decreasing sleep deprivation and circadian rhythm disorder in post-operative patients. In this study , investigators devise the two different sedatives(Dexmedetomidine and Propofol)'influence on postoperative delirium in hip fracture elderly participants under spinal anesthesia
    Detailed Description
    With a complex etiology, delirium is usually caused by various peri-operative stimuli on basis of predisposing factors, including senility, hypoxia and hypotension, pain, drug (such as pethidine, benzodiazepine, anticholinergic, and drug withdrawal), complications prior to surgery, post-operative sleep disorder. As for the mechanism of delirium, the commonly accepted hypothesis includes the decreased central cholinergic neurons function and the inflammation of central nervous system. Most of the hip fracture patients are senile, suffering generally from many complications with exposure to many drugs, and poor in nutritional status with decreased cognitive function even before the surgery in some of them, all of which are risk factors for post-operative delirium. Systematic review suggests that incidence of POD in patients undergoing elective hip arthroplasty is up to 4-53.3%. It is of great importance, therefore, to explore the effective approaches to lower POD incidence in senile patients with operation on hip fracture. Dexmedetomidine Hydrochloride is a novel highly-selective α2 adrenergic receptor agonist, and its selectivity to α2 receptor is 8 times of that of clonidine. It has multiple functions including sedation, anti-anxiety, hypnosis, analgesia and sympathetic blockade, with a wide application prospect for peri-operative patients. Researches suggest that Dex applied peri-operatively may stabilize blood pressure and heart rate, control intra-operative stress, and decrease post-operative side reactions such as nausea, vomiting, restlessness, delirium and chills. Moreover, advantages of Dex also include analgesia and reduction of opioid usage. Clinical pharmacological characteristics of Dex suggest its possible function to decrease post-operative delirium. Meanwhile, Dex seems to have a minor influence on cognition, since it has no effect on GABA receptor. Another important feature of it is that Dex induces a sleep similar to natural sleep, thereby decreasing sleep deprivation and circadian rhythm disorder in post-operative patients, and decreasing incidence of post-operative delirium. Researches evaluating the capability of Dex to decrease delirium incidence are focused on ICU sedation post to operation. Riker et al compared the sedative effect between Dex and midazolam in patients with severe mechanical ventilation, revealing a lower delirium incidence in Dex than in midazolam (54.0% vs 76.6%) in patients maintained with the same depth of sedation. Systematic review concludes that Dex in effective to prevent and treat post-operative delirium in ICU patients. In this study ,the investigators devise the two different sedatives (Dexmedetomidine and Propofol)'influence on postoperative delirium in hip fracture elderly participants under spinal anesthesia

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Delirium in Old Age
    Keywords
    Delirium Dexmedetomidine elderly

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Model Description
    Dexmedetomidine group:dexmedetomidine is given to patients under spinal anesthesia until the end of surgery propofol group:Propofol is given to patients uunder spinal anesthesia until the end of surgery
    Masking
    Outcomes Assessor
    Masking Description
    the intervention is happend in the operation,the outcome assessment is going after the operation
    Allocation
    Randomized
    Enrollment
    1000 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Dexmedetomidine Hydrochloride
    Arm Type
    Experimental
    Arm Description
    Dex Group: 0.5 μg/kg of Dex is given 10 minutes before operation through injection pump during 15 minutes. After the operation starts, the initial pumping ratio of Dex is 0.5ug/kg/h and adjusted under BIS surveillance to keep BIS between 70-80 until 30 minutes before the end of surgery. Meanwhile, OAA/S grade is evaluated every 15 minutes to maintain OAA/S at grade 4. If discrepancy occurs, OAA/S prevails.
    Arm Title
    Propofol
    Arm Type
    Active Comparator
    Arm Description
    Prop Group: Propofol is given with an initial ratio of 2-10mg/kg/h, when the operation starts. Under BIS surveillance, dripping rate is adjusted to keep BIS between 70-80 until 5 minutes before the end of surgery. Meanwhile, OAA/S grade is evaluated every 15 minutes to maintain OAA/S at grade 4. If discrepancy occurs, OAA/S prevails.
    Intervention Type
    Drug
    Intervention Name(s)
    Dexmedetomidine Hydrochloride
    Other Intervention Name(s)
    brand name :YiSi
    Intervention Description
    Dexmedetomidine is given to patients during spinal anesthesia at the dose of 0.5 μg/kg,adjusted the dose to keep BIS between 70-80 until 30 minutes before the end of surgery
    Intervention Type
    Drug
    Intervention Name(s)
    Propofol
    Other Intervention Name(s)
    Brand name:Diprivan or other brands of propofol
    Intervention Description
    Propofol is given with an initial ratio of 2-10mg/kg/h, when the operation starts,adjust the propofol's dose to keep BIS between 70-80 before the end of surgery
    Primary Outcome Measure Information:
    Title
    occurrence of postoperative delirium in postoperative 72 hours
    Description
    Evaluation of delirium is performed by trained investigational assistant who does not know the randomization of patients. Follow up is carried out before operation and at 9Am and 3Pm during post-operative day 1-3 (POD1-3). During follow up, RASS (Richmond Agitation-Sedation Scale, RASS) is used firstly to evaluate sedation of the patients, and for those with ARSS >-4 (-3~+4), the Confusion Assessment Method (CAM) is adopted for evaluation. A case consistent with delirium standard at any time point during follow up is determined to be delirium positive. Diagnosis should be confirmed for a CAM-positive patient by a psychological expert based on DSM-V standard
    Time Frame
    patient enrolled will be evaluated at 9Am and 3Pm during post-operative day 1-3 (POD1-3).At any time point above,delirium is detected,then the patient will be diagnosed as postoperative delirium. All patients enrolled is Non-delirium before surgery。
    Secondary Outcome Measure Information:
    Title
    Consumption of analgesic
    Description
    the patients will receive patient-controlled intravenous analgesia,record the consumption of intravenous analgesia in the 48 postoperative hours
    Time Frame
    record the data of comsumption of analgeisic at 48 hours after operation
    Title
    Times of intra-operative occurrence of hypotension, bradycardia, hypertension and tachycardia that need treatment.
    Description
    assess the adverse effect of anaesthetic
    Time Frame
    during the operation
    Title
    Score of quality of post-operative sleeping
    Description
    Score of sleeping quality is evaluated based on the some questions during follow up
    Time Frame
    quality of sleeping will be assessed at 9Am during post-operative day 1-3
    Title
    Hospital stay
    Description
    the duration from the day of operation to the date meeting discharge criteria as determined by doctor in charge
    Time Frame
    record the days of hospital stay at the 30 days after surgery
    Title
    Post-operative complications besides delirium
    Description
    complications besides delirium ,such as vomiting,nausea,hypotention,hypertention,bradycardia
    Time Frame
    observe and evaluate complications at the 30 days after surgery
    Title
    Mortality up to day 30 post to operation
    Description
    Data for 30-day survival is collected through telephone follow up by the assistant.
    Time Frame
    the data will be collected after 30 days of operation
    Title
    pain score
    Description
    describe severity of the pain the patient feel using Numerical Rating Scale (NRS)
    Time Frame
    Pain score will be evaluated at time point of operation, 1,6,24, 48 hours after operation, using NRS score

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    65 Years
    Maximum Age & Unit of Time
    90 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Acquisition of informed consent, Patients with hip fracture surgery under lumbar anesthesia, Grade II to III based on American Society of Anesthesiologists ASA classification, Age ≥65 and ≤90 years old. Exclusion Criteria: History of psychiatric disease or a disease needing long-term exposure to psychotropic drugs (dementia, schizophrenia), or history of alcoholic abuse. More than 8 errors in preoperative Simplified Psychology and Mental Status Questionnaire (SPMSQ) , and diagnosed as severe cognitive impairment. CAM positive diagnosed preoperatively. Any cerebrovascular accident occurring within 3 months, such as cerebral stroke or transient ischemic attack (TIA). Systolic pressure < 90mmHg and diastolic pressure < 60mm Hg at the preoperative follow up or HR< 50/minute. History of heat failure or EF<30% as shown by ultrasound cardiogram; degree 2 type 2 and degree 3 atrioventricular block. History of active heart disease (such as acute cardiac infarction, unstable angina pectoris) Severe abnormality in hepatic or renal function (severe abnormality in liver function: more than 2-times increase than upper normal limit in any one of the markers including ALT,, conjugated bilirubin, AST, ALP, total bilirubin; severe abnormality in renal function; Cr clearance<30ml/min), Scr>443μmol/L. Diabetes patients with severe complications of diabetes (Diabetic ketoacidosis, hyperosmolar coma, various infections, macrovascular diseases, and diabetic nephropathy) Patients with severe infection. Postoperative PaO2<60mmHg or SpO2<92%. Participation in clinical trials of other drugs within past 30 days. Disturbed verbal communication, and unable to accomplish the test on cognition. Patients with prosthesis fracture or restoration; hip fracture but complicated with severe trauma in other sites. Being allergic to investigational drug or having contradiction of lumbar anesthesia.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Zhang XiaoGuang, Doctor
    Phone
    +86 13641995733
    Email
    zhangxg@fudan.edu.cn
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Xue ZhangGang, doctor
    Organizational Affiliation
    Anesthesiology Department of Shanghai Zhongshan Hospital
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    How Different Sedatives Affect Hip Fracture Patient's Postoperative Delirium

    We'll reach out to this number within 24 hrs